BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12

• Press Releases

  Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

  January 6, 2026

   · 

  5 min read
• Press Releases

  VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

  January 6, 2026

   · 

  4 min read
• Press Releases

  Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

  January 6, 2026

   · 

  4 min read
• Press Releases

  Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer

  January 6, 2026

   · 

  2 min read
• Press Releases

  Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

  January 6, 2026

   · 

  1 min read
• Press Releases

  CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

  January 6, 2026

   · 

  1 min read
• Press Releases

  Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

  January 6, 2026

   · 

  6 min read
• Press Releases

  Sparrow Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Clofutriben for Difficult-to-Control Type 2 Diabetes

  January 6, 2026

   · 

  5 min read
• Press Releases

  Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026

  January 6, 2026

   · 

  7 min read
• Press Releases

  Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

  January 6, 2026

   · 

  5 min read